Octreotide Acetate CAS:79517-01-4

Octreotide acetate has multiple therapeutic applications, including the treatment of acromegaly, carcinoid tumors, and vasoactive intestinal peptide-secreting tumors. In acromegaly, a condition characterized by excessive growth hormone production and subsequent tissue overgrowth, octreotide acetate is used to help normalize hormone levels and alleviate symptoms such as enlarged hands, feet, and facial features. For individuals with carcinoid tumors, which often originate in the digestive tract or lungs and produce excess hormones, octreotide acetate can help mitigate the effects of these hormones, such as flushing, diarrhea, and difficulty breathing. Additionally, in the case of vasoactive intestinal peptide-secreting tumors, which can lead to chronic diarrhea and abdominal pain due to excessive hormone secretion, octreotide acetate offers symptomatic relief by reducing hormone levels. The medication is available in short-acting and long-acting formulations, allowing for options based on the specific needs of individual patients. Short-acting octreotide acetate injections are typically administered several times a day, whereas long-acting release formulations may be administered less frequently, ranging from once every 2 weeks to once every 4 weeks, depending on the condition being treated and the patient's response to the medication. Patients receiving octreotide acetate should be closely monitored for potential side effects, which can include gastrointestinal disturbances, such as diarrhea, nausea, and abdominal discomfort, as well as potential complications like gallstones or changes in blood glucose levels. Regular communication with healthcare providers is essential to assess the medication's effectiveness and manage any adverse effects that may arise. It's important for patients using octreotide acetate to maintain open dialogue with their healthcare team, as dosage adjustments and additional supportive therapies may be necessary to optimize symptom control and quality of life. By working collaboratively with healthcare professionals, individuals can maximize the benefits of octreotide acetate in addressing the underlying hormonal imbalances associated with these specific medical conditions.